Holen Sie sich die Stockscreener-App
41.51
0.92%
0.38
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.48%
69.22
|
69.55 | 47.73 | 37.50 | 31.60 |
Operating Expenses
|
6.31%
95.69
|
102.14 | 72.87 | 61.77 | 58.75 |
| Benefits Costs and Expenses |
10.58%
93.88
|
104.99 | 71.06 | 111.22 | 61.53 |
| Costs And Expenses |
10.58%
93.88
|
104.99 | 71.06 | 111.22 | 61.53 |
| Operating Income/Loss |
18.77%
-26.47
|
-32.59 | -25.15 | -24.27 | -27.15 |
| Income/Loss From Continuing Operations Before Tax |
30.42%
-24.66
|
-35.43 | -23.34 | -73.72 | -29.93 |
| Income Tax Expense/Benefit |
177.33%
0.624
|
0.225 | 0.249 | 0.316 | 0.201 |
| Income/Loss From Continuing Operations After Tax |
29.11%
-25.28
|
-35.66 | -23.59 | -74.04 | -30.13 |
|
Net Income/Loss
|
29.11%
-25.28
|
-35.66 | -23.59 | -74.04 | -30.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,354%
46.93
|
1.9121 | 41.10 | 38.11 | 37.68 |
| Diluted Average Shares |
2,354%
46.93
|
1.9121 | 41.10 | 38.11 | 37.68 |
| Basic Earnings Per Share |
25.00%
-0.54
|
-0.72 | -0.57 | -1.94 | -0.80 |
| Diluted Earnings Per Share |
25.00%
-0.54
|
-0.72 | -0.57 | -1.94 | -0.80 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):